Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02409017 · ClinicalTrials.gov registry record · NA

A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial

A NA study, sponsored by WellSpan Health.

Terminated
Registry status
NA
Development phase
20
Enrollment target

NCT02409017 is a NA study that was terminated before completion, run by WellSpan Health. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02409017, a NA study, was terminated before completion, sponsored by WellSpan Health.

TERMINATED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

To assess which of two commonly utilized insulin drip protocols has better outcomes when used during the labor process.

Interventions

  • PROCEDURE Insulin drip

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-04
Est. Completion 2016-07
Phase NA

Sponsor

WellSpan Health

21 total trials

What the Registry Record Tells You About NCT02409017

The ClinicalTrials.gov registry entry for NCT02409017 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Insulin drip is the first listed.

NCT02409017 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02409017 about?

NCT02409017 is a clinical study titled "A Comparison of Insulin Drip Protocols in Labor: A Randomized Trial". To assess which of two commonly utilized insulin drip protocols has better outcomes when used during the labor process.

What is the current status of trial NCT02409017?

This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2015-04. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02409017?

The interventions under investigation include: Insulin drip (PROCEDURE).

Who is sponsoring clinical trial NCT02409017?

This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.